These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 38283929)

  • 21. Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor.
    Koschinsky ML; Stroes ESG; Kronenberg F
    Pharmacol Res; 2023 Aug; 194():106843. PubMed ID: 37406784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease.
    Verweij SL; de Ronde MWJ; Verbeek R; Boekholdt SM; Planken RN; Stroes ESG; Pinto-Sietsma SJ
    J Clin Lipidol; 2018; 12(3):597-603.e1. PubMed ID: 29550494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein.
    Saeed A; Virani SS
    Front Biosci (Landmark Ed); 2018 Jan; 23(6):1099-1112. PubMed ID: 28930591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target.
    Di Fusco SA; Arca M; Scicchitano P; Alonzo A; Perone F; Gulizia MM; Gabrielli D; Oliva F; Imperoli G; Colivicchi F
    Heart; 2022 Dec; 109(1):18-25. PubMed ID: 35288443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a benefit of aspirin therapy for primary prevention to reduce the risk of atherosclerotic cardiovascular disease in patients with elevated Lipoprotein (a)-A review of the evidence.
    Sukkari MH; Al-Bast B; Al Tamimi R; Giesing W; Siddique M
    Am J Prev Cardiol; 2023 Sep; 15():100579. PubMed ID: 37736358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus and guidelines on lipoprotein(a) - seeing the forest through the trees.
    Kronenberg F; Mora S; Stroes ESG
    Curr Opin Lipidol; 2022 Dec; 33(6):342-352. PubMed ID: 36251423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses.
    Stürzebecher PE; Schorr JJ; Klebs SHG; Laufs U
    Atherosclerosis; 2023 Feb; 367():24-33. PubMed ID: 36764050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?].
    de Brouckère V; Liénart F; Ducobu J
    Rev Med Brux; 2010; 31(3):171-6. PubMed ID: 20687444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) and mortality-a high risk relationship.
    Klingel R; Heibges A; Fassbender C
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):13-19. PubMed ID: 30838554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?
    Catapano AL; Daccord M; Damato E; Humphries SE; Neely RDG; Nordestgaard BG; Pistollato M; Steinhagen-Thiessen E
    Atherosclerosis; 2022 May; 349():136-143. PubMed ID: 35292153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?
    Makris A; Barkas F; Sfikakis PP; Liberopoulos E; Filippatos TD; Ray KK; Agouridis AP
    Atheroscler Plus; 2023 Dec; 54():1-6. PubMed ID: 37720252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis.
    Zhang W; Speiser JL; Ye F; Tsai MY; Cainzos-Achirica M; Nasir K; Herrington DM; Shapiro MD
    J Am Coll Cardiol; 2021 Sep; 78(11):1083-1094. PubMed ID: 34503676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a new apolipoprotein(a) isoform-independent assay for serum Lipoprotein(a).
    Dembinski T; Nixon P; Shen G; Mymin D; Choy PC
    Mol Cell Biochem; 2000 Apr; 207(1-2):149-55. PubMed ID: 10888241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy for children with elevated levels of lipoprotein(a): future directions.
    de Boer LM; Wiegman A; Swerdlow DI; Kastelein JJP; Hutten BA
    Expert Opin Pharmacother; 2022 Oct; 23(14):1601-1615. PubMed ID: 36047306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein (a): Recent Updates on a Unique Lipoprotein.
    Saeed A; Kinoush S; Virani SS
    Curr Atheroscler Rep; 2021 Jun; 23(8):41. PubMed ID: 34146181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies.
    Bhatia HS; Wilkinson MJ
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.
    Schettler VJJ; Neumann CL; Peter C; Zimmermann T; Julius U; Hohenstein B; Roeseler E; Heigl F; Grützmacher P; Blume H; Klingel R; Vogt A;
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):33-38. PubMed ID: 30838552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association of Lipoprotein(a) and Neutrophil-to-Lymphocyte Ratio Combination with Atherosclerotic Cardiovascular Disease in Chinese Patients.
    Wang X; Chen X; Wang Y; Peng S; Pi J; Yue J; Meng Q; Liu J; Zheng L; Chan P; Tomlinson B; Liu Z; Zhang Y
    Int J Gen Med; 2023; 16():2805-2817. PubMed ID: 37426518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
    Kronenberg F; Mora S; Stroes ESG; Ference BA; Arsenault BJ; Berglund L; Dweck MR; Koschinsky M; Lambert G; Mach F; McNeal CJ; Moriarty PM; Natarajan P; Nordestgaard BG; Parhofer KG; Virani SS; von Eckardstein A; Watts GF; Stock JK; Ray KK; Tokgözoğlu LS; Catapano AL
    Eur Heart J; 2022 Oct; 43(39):3925-3946. PubMed ID: 36036785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein(a) and Cardiovascular Disease in Chinese Population: A Beijing Heart Society Expert Scientific Statement.
    Li JJ; Ma CS; Zhao D; Yan XW;
    JACC Asia; 2022 Nov; 2(6):653-665. PubMed ID: 36444328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.